Verduri Alessia, O'Neill Martin, Ghinassi Federica, Guidotti Federico, Simeone Maria Serena, Ruggieri Valentina, Clini Enrico, Hewitt Jonathan
Department of Surgical and Medical Sciences, Respiratory Unit, Hospital Policlinico, University of Modena and Reggio Emilia, Modena, Italy.
Department of Population Medicine, Cardiff University, Cardiff, Wales, UK.
Sci Prog. 2025 Jul-Sep;108(3):368504251347114. doi: 10.1177/00368504251347114. Epub 2025 Jul 21.
BackgroundCognitive Impairment (CI) represents an important extra-pulmonary feature of Chronic Obstructive Pulmonary Disease (COPD), in which its prevalence remains under-recognised. The Montreal Cognitive Assessment (MoCA) is a validated screening test for detecting CI.ObjectivesThe use of the MoCA in clinically stable COPD in routine practice. Secondary aim: CI prevalence in COPD.DesignFeasibility study.MethodsQuantitative and qualitative data were collected in 30 COPD patients, aged ≥65 years, at the Outpatient Department in Modena (Italy).ResultsThe MoCA administration was on average 11 min. Patient feedback was positive. The COPD participants (mean age 75 years) viewed the test favourably and felt that understanding more about cognitive function would help improve their care. The median MoCA score was 23 with 10% of patients had moderate CI. The prevalence of CI was 84%.ConclusionThe MoCA is not time-consuming and should be incorporated in daily routine to identify CI in COPD, in which the prevalence of mild CI remains high. Results warrant further studies in larger populations to confirm feasibility in clinical practice.
背景
认知障碍（CI）是慢性阻塞性肺疾病（COPD）的一项重要肺外特征，但其患病率仍未得到充分认识。蒙特利尔认知评估量表（MoCA）是一种经过验证的用于检测CI的筛查测试。
目的
在日常实践中，将MoCA应用于临床稳定的COPD患者。次要目的：COPD患者中CI的患病率。
设计
可行性研究。
方法
在意大利摩德纳门诊部收集了30名年龄≥65岁的COPD患者的定量和定性数据。
结果
MoCA测试平均用时11分钟。患者反馈良好。COPD参与者（平均年龄75岁）对该测试评价较高，并认为更多地了解认知功能有助于改善他们的护理。MoCA评分中位数为23分，10%的患者有中度CI。CI的患病率为84%。
结论
MoCA测试不耗时，应纳入日常工作中以识别COPD患者中的CI，其中轻度CI的患病率仍然很高。结果有待在更大规模人群中进行进一步研究，以证实其在临床实践中的可行性。
